Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A solid budget helps young professionals manage irregular income and set aside funds for future goals.
19,978 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
A tech-heavy portfolio is getting a diversification push as AVUV draws new attention among 38-year-olds with $500k sa...
Bilt rolls out an AI-driven Neighborhood Concierge to challenge Amazon in the home-commerce space, promising seamless...
Rising private valuations for SpaceX are fueling chatter about a Tesla takeover. Market participants say the odds spa...
Morph will host USDC and Circle's Cross-Chain Transfer Protocol, enabling standardized, cross-chain settlement for pa...
Retiring in 2027 brings new challenges and opportunities. Ask these three questions your financial advisor to secure ...
Bitcoin sits around $66,800 as the BITO ETF regains attention amid competition from cheaper spot BTC products. Invest...
A focused duplex hunt in St. Louis turned into an eight-unit treasure, thanks to bold moves, solid numbers, and a kna...
As 2025 closes, star bulk (sblk) enters a new chapter. This guide breaks down the Q4 2025 results, fleet strategy, ba...
Alphabet signals a strategic pivot as enterprise AI becomes the main growth driver. Google Cloud surges, and a massiv...
Rocket Lab is shaping the small-launch landscape, and the company’s 2025 earnings story matters for investors. This g...
A fresh OpenAI policy hire has warned that government monopoly over frontier AI testing could slow innovation and rai...